Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
23 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/celltrions-yuflyma-adalimumab-aaty-receives-fda-interchangeability-designation-for-all-its-approved-dosage-forms-and-strengths-302464475.html
22 May 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761091
21 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/celltrions-yuflyma-adalimumab-aaty-receives-fda-interchangeability-designation-for-all-its-approved-dosage-forms-and-strengths-302462600.html
28 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/celltrion-to-present-six-abstracts-in-inflammatory-bowel-disease-ibd-at-2025-digestive-disease-week-ddw-302438202.html
28 Apr 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761338
27 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/27/3068834/0/en/Abpro-and-Celltrion-Unveil-Preclinical-Data-for-ABP-102-CT-P72-at-AACR-2025-Showcasing-Potential-Best-in-Class-HER2-x-CD3-T-Cell-Engager.html
ABOUT THIS PAGE
Celltrion is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Infliximab bulk with JDMF offered by Celltrion
Find a price of Trastuzumab bulk with JDMF offered by Celltrion
Find a price of Infliximab bulk offered by Celltrion